BackTourmaline Bio Overview

Tourmaline Bio Other Current Liabilities

Track Tourmaline Bio's other current liabilities ($6.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$6.78M
80.80% YoYΔ $3.03M vs prior year quarter

Peer average

Loading

Tourmaline Bio Other Current Liabilities History

Loading

Tourmaline Bio vs. peers: Other Current Liabilities Comparison

Loading

Tourmaline Bio Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tourmaline Bio (TRML) FAQ

As of the most recent data (June 2025), TRML shows a other current liabilities of $6.8M. That compares with $3.8M in the prior-year period — up 80.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRML's other current liabilities is now $6.8M (was $3.8M) — a 80.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tourmaline Bio is outperforming or lagging.

Tracking TRML's other current liabilities over time shows whether Tourmaline Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $6.8M That compares with $3.8M in the prior-year period — up 80.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Tourmaline Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $6.8M) with ownership activity and broader fundamentals.

Tourmaline Bio's other current liabilities is $6.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.